Achieve Life Sciences, Inc.
ACHV
$5.99
$0.407.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 15.85% | 60.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.27% | 16.95% | |||
| Operating Income | -0.27% | -16.95% | |||
| Income Before Tax | -1.53% | -13.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.53% | -13.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.53% | -13.55% | |||
| EBIT | -0.27% | -16.95% | |||
| EBITDA | -0.25% | -17.03% | |||
| EPS Basic | 2.79% | 22.80% | |||
| Normalized Basic EPS | 2.79% | 22.78% | |||
| EPS Diluted | 2.79% | 22.80% | |||
| Normalized Diluted EPS | 2.79% | 22.78% | |||
| Average Basic Shares Outstanding | 4.43% | 47.09% | |||
| Average Diluted Shares Outstanding | 4.43% | 47.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||